Conclusions
In conclusion, the first water assisted green synthesis of thiazo-
lines and thiazines from thioamides and w-haloamines has been
reported. A clean and efficient reaction, simple isolation of the
product and wide application to a variety of substrates renders
this method practical.
Experimental
Typical experimental procedure for 2-phenyl-4,5-dihydro-[1,3]-
thiazole: 250 ml of water was added to 2-bromoethyamine
hydrobromide salt (5.5 mmol) and mixed thoroughly. To this
thiobenzamide (5 mmol) was added and the reaction mixture
Scheme 2
◦
was heated at 60–70 C for three hours. Contents were cooled
and neutralized with cold 5% sodium carbonate solution. Yellow
oil gets separated which was extracted with ethyl acetate.18 Sol-
vent removal under vacuum yielded 2-phenyl-4,5-dihydro-[1,3]-
thiazole as a yellow oil. If required the compound can be further
purified by column chromatography. Data for 1; 2-Phenyl-4,5-
dihydro-[1,3]-thiazole: Yellow oil, 1H NMR (400 MHz, CDCl3):
d 7.9-7.8 (m, 2H), 7.4-7.3 (m, 3H), 4.45 (t, 2H, J = 8.4 Hz), 3.40
(t, 2H, J = 8.0 Hz); 13C NMR (100.6 MHz, CDCl3) d 167.69,
132.87, 130.68, 128.06, 127.97, 64.85, 33.82; EIMS: m/z 163
[M+], 117, 104, 77, 60.
analysis of the reaction after two hours revealed unexpectedly,
to our delight, a direct formation of 2-phenyl-[1,3]-thiazoline
5. When the same reaction was carried out with free amino
halide only a 40% conversion into the desired product was
observed.
The formation of 5 from thioamides and protonated amino-
halide in the presence of water was rationalized as follows: first
an imidothiolinium species 3 is formed via S-alkylation. Imine
nitrogen of imidothiolic ester being mildly basic is not able to
hold the proton strongly in the presence of water and undergoes
reversible protonation. The free iminium nitrogen is attacking
the electrophilic carbon attached to the ammonium ion, leading
to clean formation of thiazoline 5. Additionally, the presence
of water is also suppressing the dehydration of thioamide.
Further, employment of protonated aminohalide is inhibiting
the undesired side reactions such as transamidation and self-
condensation leaving S-alkylation and subsequent cyclisation
the only available reaction path way.
Acknowledgements
We thank Mr Avik Mazumder, Ajeet Kumar and Mr Ajay
Pratap for NMR analysis. We also thank Dr R. Vijayaraghavan
Director, DRDE for his keen interest and encouragement. Dr
Rekha Tank gives thanks to CSIR, New Delhi for providing a
Research Associate Fellowship.
With a suitable reaction system in hand, we then set to examine
the scope of this transformation. Our results are compiled in
Table 1. Diverse thioamides bearing different functional groups
were reacted with bromoethylamine and bromopropylamine.
The reaction of bromopropylamine with thioamides yielded
2-substituted thiazines in a similar fashion. To study the S-
alkylation with halides in water; simple alkyl halides such as
butyl iodide, butyl bromide and butyl chloride were treated
with thiobenzamide. The order of reaction was found to be
I = Br > Cl. When 2-chloroethylamine was reacted with
thiobenzamide, as per our anticipation a slow reaction occurred
and formation of corresponding nitrile and amide was also
noticed.
Thionicotinamide reacted◦with bromoethyl amine at a slightly
higher temperature 95–100 C under almost solventless condi-
tions (experimental procedure 2, ESI†). Although the desired re-
action occurred at higher temperature, it took a shorter reaction
time (15 min) to reach completion (entry 12). Thioamides having
electron withdrawing groups and sterically hindered thioamides
exhibited a similar tendency (entry 9, 10). With aliphatic and
unsubstituted or electronically rich thioamides, application of
higher temperature led to significant dehydration of thioamides
producing nitrile as a side product. Reaction of thiourea with
2-bromoethylamine hydrobromide resulted in the formation of
2-amino thiazoline (entry 15).
Notes and references
1 (a) J. A. Frump, Chem. Rev., 1971, 71, 483; T. G. Gant and A. I.
Meyers, Tetrahedron, 1994, 50, 2297; (b) The Pharmacological Basis
of Therapeutics, ed. A. G. Gilman and L. S. Goodman, McGraw-Hill,
NY, 10th edn, 2001.
2 F. Rondu, G. Lr. Bihan, X. Wang, A. Lamouri, E. Touboul, G.
Dive, T. Bellahsene, B. Pfeiffer, P. Renard, B. Guardiola-Lamaitre,
D. Mane´chez, L. Pe´nicaud, A. Ktorza and J. J. Godfroid, J. Med.
Chem., 1997, 40, 3793.
3 P. Wipf and P. C. Fritch, Tetrahedron Lett., 1994, 35, 5397.
4 R. J. Boyce, G. C. Mulqueen and G. Pattenden, Tetrahedron Lett.,
1994, 35, 5705.
5 (a) P. Wipf and S. Venkatraman, Synlett, 1997, 1; (b) E. S. Vizi, Med.
Res. Rev., 1986, 6, 431.
6 L. R. Jones, E. A. Goun, R. Shinde, J. B. Rothbard, C. H. Contag
and P. A. Wender, J. Am. Chem. Soc., 2006, 128, 6526.
7 A.-C. Gaumont, M. Gulea and J. Levillain, Chem. Rev., 2009, 109,
1371.
8 (a) S. Kwaiakowski, P. J. Crocker, A. J. Chavan, N. Imai, B. E. Haley,
D. S. Watt and R.-j. Ho, Tetrahedron Lett., 1990, 31, 2093; (b) K.
S. Ramasamy, R. Bandaru and D. Averett, J. Org. Chem., 2000, 65,
5849; (c) M. Yamakuchi, H. Matsunaga, R. Tokuda, T. Ishizuka, M.
Nakajima and T. Kunieda, Tetrahedron Lett., 2005, 46, 4019.
9 (a) H. Wenker, J. Am. Chem. Soc., 1935, 57, 1079; T. Ozturk, E. Ertas
and O. Mert, Chem. Rev., 2007, 107, 5210; (b) B. Yde, N. M. Yousif,
U. Pedersen, I. Thomsen and S. O. Lawesson, Tetrahedron, 1984, 40,
2047; (c) O. E. Jensen, S. O. Laweson, R. Bardi, A. M. Piazzesi and
C. Toniolo, Tetrahedron, 1985, 41, 5595.
10 H. Vorbruggen and K. Krolikiewicz, Tetrahedron Lett., 1981, 22,
4471.
1650 | Green Chem., 2011, 13, 1648–1651
This journal is
The Royal Society of Chemistry 2011
©